Multi User License - $2,999
The prevalence of various food-borne and zoonotic diseases, rising demand for livestock-derived food products, favorable government initiatives, and technological advancements in veterinary diagnostics are primarily responsible for the growth of the livestock diagnostics market.
Additionally, significant opportunities will be presented to the various market participants by emerging markets.
Product [consumables (by diseases such as bovine viral diarrhea (BVD), influenza, foot and mouth diseases (FMD), and other diseases), systems, software, technology [immunodiagnostics (including ELISA tests and other immunodiagnostic tests), molecular diagnostics (including polymerase chain reaction, and other molecular diagnostic tests), and other technologies], animal type [ruminants, poultry, swine, and other animals (including equine and fish), end user.
The consumables segment held the largest share of the overall market for livestock diagnostics, according to product category.
The commercial availability of a wide variety of reagents and consumables for various disease diagnosis and animal health screening, their recurring costs, and growing awareness that leads to its frequent use are some of the primary factors driving the expansion of this product category.
In addition, there is a significant opportunity in the livestock diagnostic consumables market due to the emergence of various POC tests and assays.
The India livestock diagnostics market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.
The Indian Council of Medical Research (ICMR) today launched diagnostic kits to detect neglected infectious diseases in livestock.
The kits have been developed by ICMR’s Pune-based National Institute of Virology (NIV) in collaboration with Zydus Cadila, a global pharmaceutical company.
These kits will help in detecting infections in the animal population as they are often the hosts or reservoirs, spreading the infection to humans who come in close contact with them.
This public-private partnership will open newer avenues for many more indigenous diagnostics for public health benefits, Secretary, Department of Health Research and DG-ICMR, Soumya Swaminathan said.
These technologies will enable the detection of outbreaks of dangerous and life-threatening diseases and also give a boost to the government’s ‘Make in India’ efforts, she said.
“While tackling the neglected infectious diseases, timely diagnosis and treatment is critical.
To reach the ultimate goal of elimination of these neglected diseases, it is important to maintain a constant vigilance through appropriate diagnosis, robust surveillance, monitoring and reporting mechanisms,” Swaminathan said.
These kits will be manufactured and marketed by Zydus Diagnostics, a division of Cadila Healthcare based in Ahmedabad.
© Copyright 2017-2022. Mobility Foresights. All Rights Reserved.